Ticker: BEAM

Company Overview: Beam Therapeutics Inc. (NASDAQ: BEAM) is a biotechnology firm focused on developing precision genetic medicines. As of March 31, 2025, the company reported substantial advancements in its clinical programs but continues to incur significant losses. Key Financial Highlights: Lic...